AAC Holdings, Inc. (AAC)
  • CONTENT
AAC Holdings, Inc. (AAC)
AAC Holdings, Inc. (AAC)
AAC Holdings, Inc. (AAC)
AAC Holdings (AAC) Reports Q2 Loss, Misses Revenue Estimates
AAC Holdings (AAC) delivered earnings and revenue surprises of -400.00% and -12.15%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: AAC Holdings (AAC) Q2 Earnings Expected to Decline
AAC Holdings (AAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AAC Holdings, Inc. (AAC) CEO Michael Cartwright on Q1 2019 Results - Earnings Call Transcript
AAC Holdings, Inc. (NYSE:AAC) Q1 2019 Earnings Conference Call May 09, 2019, 10:00 ET Company Participants Andrew McWilliams - CFO Michael Cartwright - Chairman
ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers
Gainers: Athenex (ATNX) +22%. Ovid Therapeutics (OVID) +16%. Daxor (DXR) +16%. ImmunoGen (IMGN) +16%. Guardion Health Science (GHSI) +10%. Losers: CohBar
AAC Holdings stock price target cut to $5 from $7 at Raymond James
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
Follow Us